1 |
2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride |
- |
- |
- |
- |
006 2件: 6 , 162 💬 |
2 |
Ac-203 1% topical ointment |
- |
- |
- |
- |
162 1件: 162 💬 |
3 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
4 |
Akst4290 |
- |
- |
- |
- |
006 2件: 6 , 162 💬 |
5 |
Apremilast |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 6件: 46, 50, 56, 97, 162, 271 💬 |
6 |
Arava |
- |
- |
- |
- |
046 2件: 46, 162 💬 |
7 |
Avdoralimab |
Avdoralimab |
- |
- |
- |
162 1件: 162 💬 |
8 |
Avdoralimab (iph5401) |
Avdoralimab |
- |
- |
- |
162 1件: 162 💬 |
9 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
10 |
Azathioprine or mycophenolate mofetil |
Azathioprine |
6件: D00238 D00238, D00752 D00752, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
162 1件: 162 💬 |
11 |
Benralizumab |
Benralizumab |
1件: D09874 D09874 💬 |
IL5RA 1件: IL5RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
044 4件: 44, 45, 98, 162 💬 |
12 |
Bertilimumab |
- |
- |
- |
- |
097 2件: 97, 162 💬 |
13 |
Biv009 |
- |
- |
- |
- |
061 2件: 61, 162 💬 |
14 |
Blood test |
- |
- |
- |
- |
036 5件: 36, 86, 113, 162, 299 💬 |
15 |
Carboxymethylcellulose |
Carboxymethylcellulose |
1件: D07622 D07622 💬 |
- |
- |
035 2件: 35, 162 💬 |
16 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
17 |
Cc-10004 |
- |
- |
- |
- |
046 5件: 46, 56, 97, 162, 271 💬 |
18 |
Cellcept® in autoimmune bullous dermatoses |
- |
- |
- |
- |
035 2件: 35, 162 💬 |
19 |
Cellulose |
Microcrystalline cellulose |
1件: D00093 D00093 💬 |
- |
- |
035 4件: 35, 53, 96, 162 💬 |
20 |
Clobetasol |
Clobetasol |
1件: D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
039 4件: 39, 46, 51, 162 💬 |
21 |
Clobetasol 0.05% topical ointment |
Clobetasol |
1件: D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
22 |
Clobetasol propionate |
Clobetasol |
2件: D01272 D01272, D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 2件: 46, 162 💬 |
23 |
Clobetasol propionate + methotrexate |
Clobetasol |
4件: D00142 D00142, D01272 D01272, D02115 D02115, D07715 D07715 💬 |
DHFR 3件: DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
162 1件: 162 💬 |
24 |
Clobetasol propionate alone |
Clobetasol |
2件: D01272 D01272, D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
25 |
Clobetasol propionate cream treatment |
Clobetasol |
2件: D01272 D01272, D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
26 |
Collagenase |
Collagenase clostridium histolyticum |
1件: D09596 D09596 💬 |
- |
- |
162 1件: 162 💬 |
27 |
Cortancyl |
Prednisone acetate |
1件: D08416 D08416 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 3件: 35, 41, 162 💬 |
28 |
Cortancyl 20 mg |
Prednisone acetate |
1件: D08416 D08416 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 2件: 35, 162 💬 |
29 |
Cotton |
Cotton |
- |
- |
- |
035 2件: 35, 162 💬 |
30 |
Cultivated oral mucosal epithelial sheet transplantation |
- |
- |
- |
- |
038 2件: 38, 162 💬 |
31 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
32 |
Cyclophosphamide 50mg oral tablet |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
162 1件: 162 💬 |
33 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
34 |
Data report |
- |
- |
- |
- |
162 1件: 162 💬 |
35 |
Dermoval |
- |
- |
- |
- |
035 2件: 35, 162 💬 |
36 |
Device: carboxymethylcellulose with ionic silver (aquacel ag) |
Carboxymethylcellulose |
1件: D07622 D07622 💬 |
- |
- |
035 2件: 35, 162 💬 |
37 |
Device: cellulose acetate with petrolatum |
Acetate |
3件: D00093 D00093, D05304 D05304, D05331 D05331 💬 |
- |
- |
035 2件: 35, 162 💬 |
38 |
Device: cotton gauze with petrolatum |
Cotton |
2件: D05304 D05304, D05331 D05331 💬 |
- |
- |
035 2件: 35, 162 💬 |
39 |
Device: nanocrystalline silver (acticoat) |
Silver |
- |
- |
- |
035 2件: 35, 162 💬 |
40 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
41 |
Dexamethasone 0.5mg/5ml solution |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 2件: 35, 162 💬 |
42 |
Dexamethasone 0.5mg/5ml solution in mucolox™ |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 2件: 35, 162 💬 |
43 |
Df2156a |
- |
- |
- |
- |
162 1件: 162 💬 |
44 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
45 |
Dupilumab |
Dupilumab |
1件: D10354 D10354 💬 |
IL4R 1件: IL4R 💬 |
Cytokine-cytokine receptor interaction 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 4件: 51, 98, 160, 162 💬 |
46 |
Dupixent |
- |
- |
- |
- |
098 3件: 98, 160, 162 💬 |
47 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
48 |
Halometasone |
Halometasone |
1件: D07202 D07202 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
49 |
Imatinib |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
50 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
51 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 8件: 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
52 |
Iph5401 |
- |
- |
- |
- |
162 1件: 162 💬 |
53 |
Ixekizumab |
Ixekizumab |
1件: D10071 D10071 💬 |
IL17A 1件: IL17A 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
036 5件: 36, 37, 162, 269, 271 💬 |
54 |
Ladarixin |
Ladarixin |
- |
- |
- |
162 1件: 162 💬 |
55 |
Leflunomide |
Leflunomide |
1件: D00749 D00749 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
56 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
57 |
Mabthéra |
- |
- |
- |
- |
035 2件: 35, 162 💬 |
58 |
Mathéra |
- |
- |
- |
- |
035 2件: 35, 162 💬 |
59 |
Medrone |
- |
- |
- |
- |
046 4件: 46, 51, 83, 162 💬 |
60 |
Mepolizumab |
Mepolizumab |
1件: D04923 D04923 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
044 4件: 44, 45, 98, 162 💬 |
61 |
Mepolizumab (a-il-5 antibody) |
Mepolizumab |
1件: D04923 D04923 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
162 1件: 162 💬 |
62 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
63 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
64 |
Minocycline |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
002 13件: 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
65 |
Mometasone |
Mometasone |
3件: D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 162 💬 |
66 |
Mometasone furoate |
Mometasone |
3件: D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 162 💬 |
67 |
Mtx |
- |
- |
- |
- |
035 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
68 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
69 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
70 |
Myfortic |
- |
- |
- |
- |
049 5件: 49, 66, 162, 222, 228 💬 |
71 |
Myfortic 180 mg |
- |
- |
- |
- |
162 1件: 162 💬 |
72 |
Myfortic 180 mg filmtabletten |
- |
- |
- |
- |
162 1件: 162 💬 |
73 |
Nicotinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 6件: 2 , 6 , 18, 49, 162, 191 💬 |
74 |
Nnc0215-0384 |
- |
- |
- |
- |
046 2件: 46, 162 💬 |
75 |
Npb-01 |
- |
- |
- |
- |
013 3件: 13, 14, 162 💬 |
76 |
Omalizumab |
Omalizumab |
1件: D05251 D05251 💬 |
FCER1A 1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
046 7件: 46, 53, 65, 98, 162, 226, 299 💬 |
77 |
Oral corticosteroids (ocs) |
- |
- |
- |
- |
162 1件: 162 💬 |
78 |
Otezla |
- |
- |
- |
- |
056 2件: 56, 162 💬 |
79 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 1件: 162 💬 |
80 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
81 |
Petrolatum |
Petrolatum |
2件: D05304 D05304, D05331 D05331 💬 |
- |
- |
035 3件: 35, 158, 162 💬 |
82 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
83 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
84 |
Procedure: bone densitometry |
- |
- |
- |
- |
162 1件: 162 💬 |
85 |
Procedure: clobetasol propionate |
Clobetasol |
2件: D01272 D01272, D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
86 |
Procedure: collagenase |
Collagenase clostridium histolyticum |
1件: D09596 D09596 💬 |
- |
- |
162 1件: 162 💬 |
87 |
Procedure: impedance analysis |
- |
- |
- |
- |
162 1件: 162 💬 |
88 |
Procedure: radiographs of the thoracic and lumbar spine |
- |
- |
- |
- |
162 1件: 162 💬 |
89 |
Qge031 |
- |
- |
- |
- |
162 1件: 162 💬 |
90 |
Restasis |
- |
- |
- |
- |
053 2件: 53, 162 💬 |
91 |
Riboflavin |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬 |
92 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
93 |
Rituximab 1g iv |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
162 1件: 162 💬 |
94 |
Rituximab combined with omalizumab |
Omalizumab |
2件: D02994 D02994, D05251 D05251 💬 |
FCER1A 2件: FCER1A, MS4A1 💬 |
Asthma 5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
162 1件: 162 💬 |
95 |
Rva576 |
- |
- |
- |
- |
062 3件: 62, 109, 162 💬 |
96 |
Silver |
Silver |
- |
- |
- |
035 2件: 35, 162 💬 |
97 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
98 |
Simvastatin-ratiopharm |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
162 1件: 162 💬 |
99 |
Simvastatin-ratiopharm® |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
162 1件: 162 💬 |
100 |
Solu-medrone |
- |
- |
- |
- |
051 3件: 51, 83, 162 💬 |
101 |
Tildrakizumab |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 2件: 162, 271 💬 |
102 |
Tildrakizumab prefilled syringe |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 1件: 162 💬 |
103 |
Topical infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
038 3件: 38, 39, 162 💬 |
104 |
Treatment systemic therapy (prednisone) |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
105 |
Treatment with systemic therapy (doxycycline) |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
162 1件: 162 💬 |
106 |
Treatment with systemic therapy (methotrexate) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
162 1件: 162 💬 |
107 |
Treatment with systemic therapy (prednisone) |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
108 |
Treatment with topical superpotent corticosteroid therapy |
- |
- |
- |
- |
162 1件: 162 💬 |
109 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 8件: 46, 66, 67, 96, 162, 222, 224, 271 💬 |
110 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |